Cookson Peirce & CO Inc Repligen Corp Transaction History

Cookson Peirce & CO Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$148.08 - $206.57 $1.17 Million - $1.63 Million	-7,888 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$122.51 - $158.27 $531,938 - $687,208	4,342 Added 122.45%	7,888 $1.16 Million
Q2 2020 Aug 07, 2020	BUY	$94.33 - $140.48 $47,259 - $70,380	501 Added 16.45%	3,546 $438,000
Q1 2020 May 04, 2020	BUY	$84.96 - $109.14 $258,703 - $332,331	3,045 New	3,045 $293,000

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Cookson Peirce & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Cookson Peirce & CO Inc with notifications on news.